drugset / Trial / NCT04509219

Methylprednisolone Pulse Therapy for Coronary Artery Dilatation or Aneurysm Formation in Kawasaki Disease

NCT04509219

Phase 1 Unknown 10 enrolled Chang Gung Memorial Hospital
NaSingle-groupOpen-labelTreatment

Summary

In this study, the investigator plan to prescribe Methylprednisolone pulse therapy in Kawasaki disease patients with coronary artery lesions or aneurysm formation beyond acute stage to investigate the role for vasculitis of KD or regression of dilatation.

Timeline

Start
2020-04-15
Primary completion
2021-04-15
Completion
2023-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylprednisolone Other / unclassified 30 mg/kg

Indications